TI
IONS icon

Tidal Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Tidal Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.51M Buy
34,432
+16,524
+92% +$1.3M 0.01% 1076
2025
Q4 		$1.42M Buy
+17,908
New +$1.35M ﹤0.01% 1091
2025
Q2 		– Sell
-21,833
Closed -$659K – 1986
2025
Q1 		$659K Buy
21,833
+4,426
+25% +$145K 0.01% 1175
2024
Q4 		$609K Sell
17,407
-1,501
-8% -$56.1K ﹤0.01% 1277
2024
Q3 		$757K Sell
18,908
-42
-0.2% -$1.95K 0.01% 1151
2024
Q2 		$903K Sell
18,950
-1,455
-7% -$59.7K 0.01% 951
2024
Q1 		$885K Buy
+20,405
New +$973K 0.01% 929
2023
Q4 		– Sell
-4,427
Closed -$201K – 1469
2023
Q3 		$201K Buy
+4,427
New +$183K 0.01% 1220
2022
Q4 		– Sell
-4,667
Closed -$206K – 1157
2022
Q3 		$206K Sell
4,667
-2,940
-39% -$124K 0.01% 948
2022
Q2 		$282K Buy
7,607
+2,030
+36% +$76.5K 0.01% 802
2022
Q1 		$207K Buy
+5,577
New +$183K 0.01% 1007

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tidal Investments's IONS Position: Q1 2026 in Review

Tidal Investments increased its Ionis Pharmaceuticals (IONS) stake by 92% in Q1 2026, buying an estimated $1.3M and bringing the position to 34,432 shares worth $2.51M. The position accounts for 0.01% of the portfolio, ranked #1076.

Tidal Investments first reported a position in IONS in Q1 2022 and has held it in 11 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Tidal Investments held 34,432 shares of Ionis Pharmaceuticals worth $2.51M as of Q1 2026.
  • Tidal Investments bought 16,524 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.3M.
  • Ionis Pharmaceuticals made up 0.01% of Tidal Investments's portfolio in Q1 2026, its #1076 holding.
  • Tidal Investments first reported a position in Ionis Pharmaceuticals in Q1 2022 and has held it in 11 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.